Pentosan Polysulfate
Also known as: PPS, Elmiron
Semi-synthetic sugar-based compound (not strictly a peptide). Taken by mouth as Elmiron, it is FDA-approved for bladder pain from interstitial cystitis; it has also been studied for osteoarthritis.
Evidence
Moderate
FDA status
FDA-approved
Source
Semi-synthetic derivative from beechwood hemicellulose
Overview
Semi-synthetic sugar-based compound (not strictly a peptide). Taken by mouth as Elmiron, it is FDA-approved for bladder pain from interstitial cystitis; it has also been studied for osteoarthritis.
Mechanism of Action
Stimulates proteoglycan synthesis and incorporation into cartilage ECM, inhibits MMP-3 and other degradative enzymes, enhances TIMP-3 levels, reduces inflammatory cytokines (IL-1, TNF-α), improves subchondral bone blood flow, exhibits mild antithrombotic and fibrinolytic activity.
What research has looked at
Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.
- Cartilage breakdown in lab and animal studies
- Cartilage matrix production in lab studies
- Reduces joint inflammation
- Improves synovial fluid quality
- Enhances joint nutrition and microcirculation
- Pain and stiffness in small osteoarthritis trials
Researched for
Includes FDA-approved uses where marked; other items are research topics, not approved uses.
How Gabriel approaches peptides
Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. Pentosan Polysulfate isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.
Research & Evidence
Multiple preclinical studies, clinical trials in equine and human OA
FDA-approved (oral Elmiron) for interstitial cystitis. Osteoarthritis use is off-label; small trials report some benefit, and larger trials are needed. Long-term oral use is linked to a pigment change in the retina, so FDA added a warning to the label.
Safety Information
Potential Side Effects
- •Injection site pain
- •Mild bleeding risk
- •Gastrointestinal upset
- •Hair loss (rare)
- •Retinal pigmentary changes (long-term oral use)
Contraindications
- Bleeding disorders
- Active gastric ulcers
- Severe hepatic or renal impairment
Interactions
- ⚠Anticoagulants (increased bleeding risk)
- ⚠Aspirin and NSAIDs
Quick Facts
Related Peptides
BPC-157
Synthetic peptide based on a protein fragment described in human gastric juice. It's promoted online for tendon, ligament, muscle and gut healing, mostly on the strength of animal studies.
TB-500
Synthetic version of part of thymosin beta-4, a naturally occurring protein involved in cell movement and tissue repair.